Walgreens Boots Alliance, Inc. (Nasdaq: WBA) inches up in pre trading session on Friday after it announced Bryan C. Hanson’s appointment to the company’s board of directors. Hanson, a proven leader with more than 30 years of leadership experience in healthcare, health innovation, and emerging technologies, will join the board as a director on Oct. 27, 2022, and will also serve on two board committees: the compensation and leadership performance committee and the newly formed finance and technology committee.
Hanson is presently the president, CEO, and chairman of Zimmer Biomet, a worldwide medical technology company with a diverse portfolio of products and therapies aimed to improve mobility and health.
Walgreens Boots Alliance executive chairman Stefano Pessina said, “I am delighted to welcome Bryan to the WBA Board and look forward to working with him. I am certain that he will provide tremendous insight and healthcare sector knowledge as we enter our next chapter of expansion.”
CEO, Walgreens Boots Alliance, Roz Brewer stated that Bryan is an excellent addition to their board of directors, bringing with him leadership expertise in the healthcare and technology sectors, which will continue to play an important role in our consumer-centric healthcare approach.
Hanson joined Zimmer Biomet in 2017 as president, CEO, and a member of the board of directors, and was appointed chairman in 2021.
Prior to joining Zimmer Biomet, Hanson was executive vice president and group president of Medtronic’s Minimally Invasive Therapies Group, a major global healthcare technology firm that seeks and finds answers to the most difficult health challenges confronting humanity. He directed and gave strategic direction to Medtronic’s approximately $9 billion minimally invasive treatments division as a member of the company’s Executive Committee.
Hanson added throughout his career in healthcare, He have led firms devoted to helping people focus on and improve their health. He is grateful for the opportunity to work with a firm like WBA that shares this goal and is ideally positioned to affect the future of local healthcare.
